The Latest Cardiac and Vascular News
Caption Guidance, the company’s transformational ultrasound software, successfully meets primary endpoints in pivotal clinical study Food and Drug Administration (FDA) grants Breakthrough Device Designation to Caption Guidance SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ — Bay Labs, a growing medical technology company applying deep […]
Results to be Presented Highlight Deep-Learning Software Utility in Acquisition of Diagnostic-Quality Echocardiograms by Novice Scanners SAN FRANCISCO – June 18, 2019 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, […]
SAN FRANCISCO – March 13, 2019 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced the presentation of two studies assessing performance of the company’s deep learning software. The […]
Bay Labs Announces New Data that Evaluates Accuracy, Efficiency and Reproducibility of EchoGPS™ and AutoEF AI Software Results Presented at the American College of Cardiology ACC.19 68th Annual Scientific Session SAN FRANCISCO – March 13, 2019 – Bay Labs, a medical […]
SAN FRANCISCO – December 10, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, announced today a collaboration with Edwards Lifesciences focused on improving the detection of heart disease. The […]
Clinical Trial Evaluates if AI Helps Certified Medical Assistants Perform Echocardiograms and Detect Heart Disease in Primary Care Settings SAN FRANCISCO – November 13, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) […]
Study Results Presented at American Society of Echocardiography Annual Scientific Sessions NASHVILLE, Tenn. – June 25, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF […]
SAN FRANCISCO – June 19, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF software product received 510(k) clearance from the U.S. Food and Drug […]
SAN FRANCISCO–(BUSINESS WIRE)– Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced it completed $5.5 million in financing. The Series A round was led by existing investor Khosla Ventureswith participation from new […]
SAN FRANCISCO–(BUSINESS WIRE)–Bay Labs, a medical technology company at the forefront of applying artificial intelligence to cardiovascular imaging, today announced that Emeritus Professor of Medicine (Cardiology) at Emory University School of Medicine and the company’s Chief Medical Officer Randolph P. […]
